Global Tenofovir Alafenamide Fumarate Tablets Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Tenofovir Alafenamide Fumarate Tablets market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Tenofovir Alafenamide Fumarate Tablets industry chain, the market status of Hospital (Original Drugs, Generic Drugs), Clinic (Original Drugs, Generic Drugs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Tenofovir Alafenamide Fumarate Tablets.
Regionally, the report analyzes the Tenofovir Alafenamide Fumarate Tablets markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Tenofovir Alafenamide Fumarate Tablets market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Tenofovir Alafenamide Fumarate Tablets market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Tenofovir Alafenamide Fumarate Tablets industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Original Drugs, Generic Drugs).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Tenofovir Alafenamide Fumarate Tablets market.
Regional Analysis: The report involves examining the Tenofovir Alafenamide Fumarate Tablets market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Tenofovir Alafenamide Fumarate Tablets market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Tenofovir Alafenamide Fumarate Tablets:
Company Analysis: Report covers individual Tenofovir Alafenamide Fumarate Tablets manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Tenofovir Alafenamide Fumarate Tablets This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Tenofovir Alafenamide Fumarate Tablets. It assesses the current state, advancements, and potential future developments in Tenofovir Alafenamide Fumarate Tablets areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Tenofovir Alafenamide Fumarate Tablets market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Tenofovir Alafenamide Fumarate Tablets market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Tenofovir Alafenamide Fumarate Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Tenofovir Alafenamide Fumarate Tablets, with price, sales, revenue and global market share of Tenofovir Alafenamide Fumarate Tablets from 2018 to 2023.
Chapter 3, the Tenofovir Alafenamide Fumarate Tablets competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tenofovir Alafenamide Fumarate Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Tenofovir Alafenamide Fumarate Tablets market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Tenofovir Alafenamide Fumarate Tablets.
Chapter 14 and 15, to describe Tenofovir Alafenamide Fumarate Tablets sales channel, distributors, customers, research findings and conclusion.
The Global Info Research report includes an overview of the development of the Tenofovir Alafenamide Fumarate Tablets industry chain, the market status of Hospital (Original Drugs, Generic Drugs), Clinic (Original Drugs, Generic Drugs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Tenofovir Alafenamide Fumarate Tablets.
Regionally, the report analyzes the Tenofovir Alafenamide Fumarate Tablets markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Tenofovir Alafenamide Fumarate Tablets market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Tenofovir Alafenamide Fumarate Tablets market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Tenofovir Alafenamide Fumarate Tablets industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Original Drugs, Generic Drugs).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Tenofovir Alafenamide Fumarate Tablets market.
Regional Analysis: The report involves examining the Tenofovir Alafenamide Fumarate Tablets market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Tenofovir Alafenamide Fumarate Tablets market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Tenofovir Alafenamide Fumarate Tablets:
Company Analysis: Report covers individual Tenofovir Alafenamide Fumarate Tablets manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Tenofovir Alafenamide Fumarate Tablets This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Tenofovir Alafenamide Fumarate Tablets. It assesses the current state, advancements, and potential future developments in Tenofovir Alafenamide Fumarate Tablets areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Tenofovir Alafenamide Fumarate Tablets market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Tenofovir Alafenamide Fumarate Tablets market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Original Drugs
- Generic Drugs
- Hospital
- Clinic
- Other
- CSPC OUYI Pharmaceutical Co., Ltd.
- Gilead Sciences, Inc.
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Shandong Loncom Pharmaceutical Co., Ltd
- Reyoung Pharmaceutical Co., Ltd.
- Suzhou Homesun Pharmaceutical Co.,Ltd.
- Hunan Mingrui Pharmaceutical Co., Ltd.
- DESANO
- Patheon Inc.
- Suzhou Thery Pharmaceutical Inc.
- Chengdu Easton Biopharmaceuticals Co.,Ltd.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Tenofovir Alafenamide Fumarate Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Tenofovir Alafenamide Fumarate Tablets, with price, sales, revenue and global market share of Tenofovir Alafenamide Fumarate Tablets from 2018 to 2023.
Chapter 3, the Tenofovir Alafenamide Fumarate Tablets competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tenofovir Alafenamide Fumarate Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Tenofovir Alafenamide Fumarate Tablets market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Tenofovir Alafenamide Fumarate Tablets.
Chapter 14 and 15, to describe Tenofovir Alafenamide Fumarate Tablets sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Tenofovir Alafenamide Fumarate Tablets
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Original Drugs
1.3.3 Generic Drugs
1.4 Market Analysis by Application
1.4.1 Overview: Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Tenofovir Alafenamide Fumarate Tablets Market Size & Forecast
1.5.1 Global Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity (2018-2029)
1.5.3 Global Tenofovir Alafenamide Fumarate Tablets Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 CSPC OUYI Pharmaceutical Co., Ltd.
2.1.1 CSPC OUYI Pharmaceutical Co., Ltd. Details
2.1.2 CSPC OUYI Pharmaceutical Co., Ltd. Major Business
2.1.3 CSPC OUYI Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
2.1.4 CSPC OUYI Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 CSPC OUYI Pharmaceutical Co., Ltd. Recent Developments/Updates
2.2 Gilead Sciences, Inc.
2.2.1 Gilead Sciences, Inc. Details
2.2.2 Gilead Sciences, Inc. Major Business
2.2.3 Gilead Sciences, Inc. Tenofovir Alafenamide Fumarate Tablets Product and Services
2.2.4 Gilead Sciences, Inc. Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Gilead Sciences, Inc. Recent Developments/Updates
2.3 Yichang Humanwell Pharmaceutical Co., Ltd.
2.3.1 Yichang Humanwell Pharmaceutical Co., Ltd. Details
2.3.2 Yichang Humanwell Pharmaceutical Co., Ltd. Major Business
2.3.3 Yichang Humanwell Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
2.3.4 Yichang Humanwell Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Yichang Humanwell Pharmaceutical Co., Ltd. Recent Developments/Updates
2.4 Shandong Loncom Pharmaceutical Co., Ltd
2.4.1 Shandong Loncom Pharmaceutical Co., Ltd Details
2.4.2 Shandong Loncom Pharmaceutical Co., Ltd Major Business
2.4.3 Shandong Loncom Pharmaceutical Co., Ltd Tenofovir Alafenamide Fumarate Tablets Product and Services
2.4.4 Shandong Loncom Pharmaceutical Co., Ltd Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Shandong Loncom Pharmaceutical Co., Ltd Recent Developments/Updates
2.5 Reyoung Pharmaceutical Co., Ltd.
2.5.1 Reyoung Pharmaceutical Co., Ltd. Details
2.5.2 Reyoung Pharmaceutical Co., Ltd. Major Business
2.5.3 Reyoung Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
2.5.4 Reyoung Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Reyoung Pharmaceutical Co., Ltd. Recent Developments/Updates
2.6 Suzhou Homesun Pharmaceutical Co.,Ltd.
2.6.1 Suzhou Homesun Pharmaceutical Co.,Ltd. Details
2.6.2 Suzhou Homesun Pharmaceutical Co.,Ltd. Major Business
2.6.3 Suzhou Homesun Pharmaceutical Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
2.6.4 Suzhou Homesun Pharmaceutical Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Suzhou Homesun Pharmaceutical Co.,Ltd. Recent Developments/Updates
2.7 Hunan Mingrui Pharmaceutical Co., Ltd.
2.7.1 Hunan Mingrui Pharmaceutical Co., Ltd. Details
2.7.2 Hunan Mingrui Pharmaceutical Co., Ltd. Major Business
2.7.3 Hunan Mingrui Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
2.7.4 Hunan Mingrui Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hunan Mingrui Pharmaceutical Co., Ltd. Recent Developments/Updates
2.8 DESANO
2.8.1 DESANO Details
2.8.2 DESANO Major Business
2.8.3 DESANO Tenofovir Alafenamide Fumarate Tablets Product and Services
2.8.4 DESANO Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 DESANO Recent Developments/Updates
2.9 Patheon Inc.
2.9.1 Patheon Inc. Details
2.9.2 Patheon Inc. Major Business
2.9.3 Patheon Inc. Tenofovir Alafenamide Fumarate Tablets Product and Services
2.9.4 Patheon Inc. Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Patheon Inc. Recent Developments/Updates
2.10 Suzhou Thery Pharmaceutical Inc.
2.10.1 Suzhou Thery Pharmaceutical Inc. Details
2.10.2 Suzhou Thery Pharmaceutical Inc. Major Business
2.10.3 Suzhou Thery Pharmaceutical Inc. Tenofovir Alafenamide Fumarate Tablets Product and Services
2.10.4 Suzhou Thery Pharmaceutical Inc. Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Suzhou Thery Pharmaceutical Inc. Recent Developments/Updates
2.11 Chengdu Easton Biopharmaceuticals Co.,Ltd.
2.11.1 Chengdu Easton Biopharmaceuticals Co.,Ltd. Details
2.11.2 Chengdu Easton Biopharmaceuticals Co.,Ltd. Major Business
2.11.3 Chengdu Easton Biopharmaceuticals Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
2.11.4 Chengdu Easton Biopharmaceuticals Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Chengdu Easton Biopharmaceuticals Co.,Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TENOFOVIR ALAFENAMIDE FUMARATE TABLETS BY MANUFACTURER
3.1 Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Manufacturer (2018-2023)
3.2 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Manufacturer (2018-2023)
3.3 Global Tenofovir Alafenamide Fumarate Tablets Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Tenofovir Alafenamide Fumarate Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Tenofovir Alafenamide Fumarate Tablets Manufacturer Market Share in 2022
3.4.2 Top 6 Tenofovir Alafenamide Fumarate Tablets Manufacturer Market Share in 2022
3.5 Tenofovir Alafenamide Fumarate Tablets Market: Overall Company Footprint Analysis
3.5.1 Tenofovir Alafenamide Fumarate Tablets Market: Region Footprint
3.5.2 Tenofovir Alafenamide Fumarate Tablets Market: Company Product Type Footprint
3.5.3 Tenofovir Alafenamide Fumarate Tablets Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Tenofovir Alafenamide Fumarate Tablets Market Size by Region
4.1.1 Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Region (2018-2029)
4.1.2 Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Region (2018-2029)
4.1.3 Global Tenofovir Alafenamide Fumarate Tablets Average Price by Region (2018-2029)
4.2 North America Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018-2029)
4.3 Europe Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018-2029)
4.4 Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018-2029)
4.5 South America Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018-2029)
4.6 Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2029)
5.2 Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Type (2018-2029)
5.3 Global Tenofovir Alafenamide Fumarate Tablets Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2029)
6.2 Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Application (2018-2029)
6.3 Global Tenofovir Alafenamide Fumarate Tablets Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2029)
7.2 North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2029)
7.3 North America Tenofovir Alafenamide Fumarate Tablets Market Size by Country
7.3.1 North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Country (2018-2029)
7.3.2 North America Tenofovir Alafenamide Fumarate Tablets Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2029)
8.2 Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2029)
8.3 Europe Tenofovir Alafenamide Fumarate Tablets Market Size by Country
8.3.1 Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Country (2018-2029)
8.3.2 Europe Tenofovir Alafenamide Fumarate Tablets Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Market Size by Region
9.3.1 Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2029)
10.2 South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2029)
10.3 South America Tenofovir Alafenamide Fumarate Tablets Market Size by Country
10.3.1 South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Country (2018-2029)
10.3.2 South America Tenofovir Alafenamide Fumarate Tablets Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Market Size by Country
11.3.1 Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Tenofovir Alafenamide Fumarate Tablets Market Drivers
12.2 Tenofovir Alafenamide Fumarate Tablets Market Restraints
12.3 Tenofovir Alafenamide Fumarate Tablets Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Tenofovir Alafenamide Fumarate Tablets and Key Manufacturers
13.2 Manufacturing Costs Percentage of Tenofovir Alafenamide Fumarate Tablets
13.3 Tenofovir Alafenamide Fumarate Tablets Production Process
13.4 Tenofovir Alafenamide Fumarate Tablets Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Tenofovir Alafenamide Fumarate Tablets Typical Distributors
14.3 Tenofovir Alafenamide Fumarate Tablets Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Tenofovir Alafenamide Fumarate Tablets
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Original Drugs
1.3.3 Generic Drugs
1.4 Market Analysis by Application
1.4.1 Overview: Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Tenofovir Alafenamide Fumarate Tablets Market Size & Forecast
1.5.1 Global Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity (2018-2029)
1.5.3 Global Tenofovir Alafenamide Fumarate Tablets Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 CSPC OUYI Pharmaceutical Co., Ltd.
2.1.1 CSPC OUYI Pharmaceutical Co., Ltd. Details
2.1.2 CSPC OUYI Pharmaceutical Co., Ltd. Major Business
2.1.3 CSPC OUYI Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
2.1.4 CSPC OUYI Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 CSPC OUYI Pharmaceutical Co., Ltd. Recent Developments/Updates
2.2 Gilead Sciences, Inc.
2.2.1 Gilead Sciences, Inc. Details
2.2.2 Gilead Sciences, Inc. Major Business
2.2.3 Gilead Sciences, Inc. Tenofovir Alafenamide Fumarate Tablets Product and Services
2.2.4 Gilead Sciences, Inc. Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Gilead Sciences, Inc. Recent Developments/Updates
2.3 Yichang Humanwell Pharmaceutical Co., Ltd.
2.3.1 Yichang Humanwell Pharmaceutical Co., Ltd. Details
2.3.2 Yichang Humanwell Pharmaceutical Co., Ltd. Major Business
2.3.3 Yichang Humanwell Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
2.3.4 Yichang Humanwell Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Yichang Humanwell Pharmaceutical Co., Ltd. Recent Developments/Updates
2.4 Shandong Loncom Pharmaceutical Co., Ltd
2.4.1 Shandong Loncom Pharmaceutical Co., Ltd Details
2.4.2 Shandong Loncom Pharmaceutical Co., Ltd Major Business
2.4.3 Shandong Loncom Pharmaceutical Co., Ltd Tenofovir Alafenamide Fumarate Tablets Product and Services
2.4.4 Shandong Loncom Pharmaceutical Co., Ltd Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Shandong Loncom Pharmaceutical Co., Ltd Recent Developments/Updates
2.5 Reyoung Pharmaceutical Co., Ltd.
2.5.1 Reyoung Pharmaceutical Co., Ltd. Details
2.5.2 Reyoung Pharmaceutical Co., Ltd. Major Business
2.5.3 Reyoung Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
2.5.4 Reyoung Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Reyoung Pharmaceutical Co., Ltd. Recent Developments/Updates
2.6 Suzhou Homesun Pharmaceutical Co.,Ltd.
2.6.1 Suzhou Homesun Pharmaceutical Co.,Ltd. Details
2.6.2 Suzhou Homesun Pharmaceutical Co.,Ltd. Major Business
2.6.3 Suzhou Homesun Pharmaceutical Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
2.6.4 Suzhou Homesun Pharmaceutical Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Suzhou Homesun Pharmaceutical Co.,Ltd. Recent Developments/Updates
2.7 Hunan Mingrui Pharmaceutical Co., Ltd.
2.7.1 Hunan Mingrui Pharmaceutical Co., Ltd. Details
2.7.2 Hunan Mingrui Pharmaceutical Co., Ltd. Major Business
2.7.3 Hunan Mingrui Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
2.7.4 Hunan Mingrui Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hunan Mingrui Pharmaceutical Co., Ltd. Recent Developments/Updates
2.8 DESANO
2.8.1 DESANO Details
2.8.2 DESANO Major Business
2.8.3 DESANO Tenofovir Alafenamide Fumarate Tablets Product and Services
2.8.4 DESANO Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 DESANO Recent Developments/Updates
2.9 Patheon Inc.
2.9.1 Patheon Inc. Details
2.9.2 Patheon Inc. Major Business
2.9.3 Patheon Inc. Tenofovir Alafenamide Fumarate Tablets Product and Services
2.9.4 Patheon Inc. Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Patheon Inc. Recent Developments/Updates
2.10 Suzhou Thery Pharmaceutical Inc.
2.10.1 Suzhou Thery Pharmaceutical Inc. Details
2.10.2 Suzhou Thery Pharmaceutical Inc. Major Business
2.10.3 Suzhou Thery Pharmaceutical Inc. Tenofovir Alafenamide Fumarate Tablets Product and Services
2.10.4 Suzhou Thery Pharmaceutical Inc. Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Suzhou Thery Pharmaceutical Inc. Recent Developments/Updates
2.11 Chengdu Easton Biopharmaceuticals Co.,Ltd.
2.11.1 Chengdu Easton Biopharmaceuticals Co.,Ltd. Details
2.11.2 Chengdu Easton Biopharmaceuticals Co.,Ltd. Major Business
2.11.3 Chengdu Easton Biopharmaceuticals Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
2.11.4 Chengdu Easton Biopharmaceuticals Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Chengdu Easton Biopharmaceuticals Co.,Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TENOFOVIR ALAFENAMIDE FUMARATE TABLETS BY MANUFACTURER
3.1 Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Manufacturer (2018-2023)
3.2 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Manufacturer (2018-2023)
3.3 Global Tenofovir Alafenamide Fumarate Tablets Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Tenofovir Alafenamide Fumarate Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Tenofovir Alafenamide Fumarate Tablets Manufacturer Market Share in 2022
3.4.2 Top 6 Tenofovir Alafenamide Fumarate Tablets Manufacturer Market Share in 2022
3.5 Tenofovir Alafenamide Fumarate Tablets Market: Overall Company Footprint Analysis
3.5.1 Tenofovir Alafenamide Fumarate Tablets Market: Region Footprint
3.5.2 Tenofovir Alafenamide Fumarate Tablets Market: Company Product Type Footprint
3.5.3 Tenofovir Alafenamide Fumarate Tablets Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Tenofovir Alafenamide Fumarate Tablets Market Size by Region
4.1.1 Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Region (2018-2029)
4.1.2 Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Region (2018-2029)
4.1.3 Global Tenofovir Alafenamide Fumarate Tablets Average Price by Region (2018-2029)
4.2 North America Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018-2029)
4.3 Europe Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018-2029)
4.4 Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018-2029)
4.5 South America Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018-2029)
4.6 Middle East and Africa Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2029)
5.2 Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Type (2018-2029)
5.3 Global Tenofovir Alafenamide Fumarate Tablets Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2029)
6.2 Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Application (2018-2029)
6.3 Global Tenofovir Alafenamide Fumarate Tablets Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2029)
7.2 North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2029)
7.3 North America Tenofovir Alafenamide Fumarate Tablets Market Size by Country
7.3.1 North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Country (2018-2029)
7.3.2 North America Tenofovir Alafenamide Fumarate Tablets Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2029)
8.2 Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2029)
8.3 Europe Tenofovir Alafenamide Fumarate Tablets Market Size by Country
8.3.1 Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Country (2018-2029)
8.3.2 Europe Tenofovir Alafenamide Fumarate Tablets Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Market Size by Region
9.3.1 Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2029)
10.2 South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2029)
10.3 South America Tenofovir Alafenamide Fumarate Tablets Market Size by Country
10.3.1 South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Country (2018-2029)
10.3.2 South America Tenofovir Alafenamide Fumarate Tablets Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Market Size by Country
11.3.1 Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Tenofovir Alafenamide Fumarate Tablets Market Drivers
12.2 Tenofovir Alafenamide Fumarate Tablets Market Restraints
12.3 Tenofovir Alafenamide Fumarate Tablets Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Tenofovir Alafenamide Fumarate Tablets and Key Manufacturers
13.2 Manufacturing Costs Percentage of Tenofovir Alafenamide Fumarate Tablets
13.3 Tenofovir Alafenamide Fumarate Tablets Production Process
13.4 Tenofovir Alafenamide Fumarate Tablets Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Tenofovir Alafenamide Fumarate Tablets Typical Distributors
14.3 Tenofovir Alafenamide Fumarate Tablets Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. CSPC OUYI Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 4. CSPC OUYI Pharmaceutical Co., Ltd. Major Business
Table 5. CSPC OUYI Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 6. CSPC OUYI Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. CSPC OUYI Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 8. Gilead Sciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Gilead Sciences, Inc. Major Business
Table 10. Gilead Sciences, Inc. Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 11. Gilead Sciences, Inc. Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Gilead Sciences, Inc. Recent Developments/Updates
Table 13. Yichang Humanwell Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 14. Yichang Humanwell Pharmaceutical Co., Ltd. Major Business
Table 15. Yichang Humanwell Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 16. Yichang Humanwell Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Yichang Humanwell Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 18. Shandong Loncom Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 19. Shandong Loncom Pharmaceutical Co., Ltd Major Business
Table 20. Shandong Loncom Pharmaceutical Co., Ltd Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 21. Shandong Loncom Pharmaceutical Co., Ltd Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Shandong Loncom Pharmaceutical Co., Ltd Recent Developments/Updates
Table 23. Reyoung Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Reyoung Pharmaceutical Co., Ltd. Major Business
Table 25. Reyoung Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 26. Reyoung Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Reyoung Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 28. Suzhou Homesun Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Suzhou Homesun Pharmaceutical Co.,Ltd. Major Business
Table 30. Suzhou Homesun Pharmaceutical Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 31. Suzhou Homesun Pharmaceutical Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Suzhou Homesun Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 33. Hunan Mingrui Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Hunan Mingrui Pharmaceutical Co., Ltd. Major Business
Table 35. Hunan Mingrui Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 36. Hunan Mingrui Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hunan Mingrui Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 38. DESANO Basic Information, Manufacturing Base and Competitors
Table 39. DESANO Major Business
Table 40. DESANO Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 41. DESANO Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. DESANO Recent Developments/Updates
Table 43. Patheon Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Patheon Inc. Major Business
Table 45. Patheon Inc. Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 46. Patheon Inc. Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Patheon Inc. Recent Developments/Updates
Table 48. Suzhou Thery Pharmaceutical Inc. Basic Information, Manufacturing Base and Competitors
Table 49. Suzhou Thery Pharmaceutical Inc. Major Business
Table 50. Suzhou Thery Pharmaceutical Inc. Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 51. Suzhou Thery Pharmaceutical Inc. Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Suzhou Thery Pharmaceutical Inc. Recent Developments/Updates
Table 53. Chengdu Easton Biopharmaceuticals Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Chengdu Easton Biopharmaceuticals Co.,Ltd. Major Business
Table 55. Chengdu Easton Biopharmaceuticals Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 56. Chengdu Easton Biopharmaceuticals Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Chengdu Easton Biopharmaceuticals Co.,Ltd. Recent Developments/Updates
Table 58. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Tenofovir Alafenamide Fumarate Tablets Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Tenofovir Alafenamide Fumarate Tablets Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Tenofovir Alafenamide Fumarate Tablets, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Tenofovir Alafenamide Fumarate Tablets Production Site of Key Manufacturer
Table 63. Tenofovir Alafenamide Fumarate Tablets Market: Company Product Type Footprint
Table 64. Tenofovir Alafenamide Fumarate Tablets Market: Company Product Application Footprint
Table 65. Tenofovir Alafenamide Fumarate Tablets New Market Entrants and Barriers to Market Entry
Table 66. Tenofovir Alafenamide Fumarate Tablets Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Tenofovir Alafenamide Fumarate Tablets Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Tenofovir Alafenamide Fumarate Tablets Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Tenofovir Alafenamide Fumarate Tablets Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Tenofovir Alafenamide Fumarate Tablets Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Tenofovir Alafenamide Fumarate Tablets Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Tenofovir Alafenamide Fumarate Tablets Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Tenofovir Alafenamide Fumarate Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Tenofovir Alafenamide Fumarate Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Tenofovir Alafenamide Fumarate Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Tenofovir Alafenamide Fumarate Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Tenofovir Alafenamide Fumarate Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Tenofovir Alafenamide Fumarate Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Tenofovir Alafenamide Fumarate Tablets Raw Material
Table 126. Key Manufacturers of Tenofovir Alafenamide Fumarate Tablets Raw Materials
Table 127. Tenofovir Alafenamide Fumarate Tablets Typical Distributors
Table 128. Tenofovir Alafenamide Fumarate Tablets Typical Customers
List of Figures
Figure 1. Tenofovir Alafenamide Fumarate Tablets Picture
Figure 2. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Type in 2022
Figure 4. Original Drugs Examples
Figure 5. Generic Drugs Examples
Figure 6. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Other Examples
Figure 11. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Tenofovir Alafenamide Fumarate Tablets Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Tenofovir Alafenamide Fumarate Tablets by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Tenofovir Alafenamide Fumarate Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Tenofovir Alafenamide Fumarate Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Tenofovir Alafenamide Fumarate Tablets Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Tenofovir Alafenamide Fumarate Tablets Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Region (2018-2029)
Figure 53. China Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Tenofovir Alafenamide Fumarate Tablets Market Drivers
Figure 74. Tenofovir Alafenamide Fumarate Tablets Market Restraints
Figure 75. Tenofovir Alafenamide Fumarate Tablets Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Tenofovir Alafenamide Fumarate Tablets in 2022
Figure 78. Manufacturing Process Analysis of Tenofovir Alafenamide Fumarate Tablets
Figure 79. Tenofovir Alafenamide Fumarate Tablets Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Table 1. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. CSPC OUYI Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 4. CSPC OUYI Pharmaceutical Co., Ltd. Major Business
Table 5. CSPC OUYI Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 6. CSPC OUYI Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. CSPC OUYI Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 8. Gilead Sciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Gilead Sciences, Inc. Major Business
Table 10. Gilead Sciences, Inc. Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 11. Gilead Sciences, Inc. Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Gilead Sciences, Inc. Recent Developments/Updates
Table 13. Yichang Humanwell Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 14. Yichang Humanwell Pharmaceutical Co., Ltd. Major Business
Table 15. Yichang Humanwell Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 16. Yichang Humanwell Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Yichang Humanwell Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 18. Shandong Loncom Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 19. Shandong Loncom Pharmaceutical Co., Ltd Major Business
Table 20. Shandong Loncom Pharmaceutical Co., Ltd Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 21. Shandong Loncom Pharmaceutical Co., Ltd Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Shandong Loncom Pharmaceutical Co., Ltd Recent Developments/Updates
Table 23. Reyoung Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Reyoung Pharmaceutical Co., Ltd. Major Business
Table 25. Reyoung Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 26. Reyoung Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Reyoung Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 28. Suzhou Homesun Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Suzhou Homesun Pharmaceutical Co.,Ltd. Major Business
Table 30. Suzhou Homesun Pharmaceutical Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 31. Suzhou Homesun Pharmaceutical Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Suzhou Homesun Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 33. Hunan Mingrui Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Hunan Mingrui Pharmaceutical Co., Ltd. Major Business
Table 35. Hunan Mingrui Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 36. Hunan Mingrui Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hunan Mingrui Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 38. DESANO Basic Information, Manufacturing Base and Competitors
Table 39. DESANO Major Business
Table 40. DESANO Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 41. DESANO Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. DESANO Recent Developments/Updates
Table 43. Patheon Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Patheon Inc. Major Business
Table 45. Patheon Inc. Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 46. Patheon Inc. Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Patheon Inc. Recent Developments/Updates
Table 48. Suzhou Thery Pharmaceutical Inc. Basic Information, Manufacturing Base and Competitors
Table 49. Suzhou Thery Pharmaceutical Inc. Major Business
Table 50. Suzhou Thery Pharmaceutical Inc. Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 51. Suzhou Thery Pharmaceutical Inc. Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Suzhou Thery Pharmaceutical Inc. Recent Developments/Updates
Table 53. Chengdu Easton Biopharmaceuticals Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Chengdu Easton Biopharmaceuticals Co.,Ltd. Major Business
Table 55. Chengdu Easton Biopharmaceuticals Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Product and Services
Table 56. Chengdu Easton Biopharmaceuticals Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Chengdu Easton Biopharmaceuticals Co.,Ltd. Recent Developments/Updates
Table 58. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Tenofovir Alafenamide Fumarate Tablets Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Tenofovir Alafenamide Fumarate Tablets Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Tenofovir Alafenamide Fumarate Tablets, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Tenofovir Alafenamide Fumarate Tablets Production Site of Key Manufacturer
Table 63. Tenofovir Alafenamide Fumarate Tablets Market: Company Product Type Footprint
Table 64. Tenofovir Alafenamide Fumarate Tablets Market: Company Product Application Footprint
Table 65. Tenofovir Alafenamide Fumarate Tablets New Market Entrants and Barriers to Market Entry
Table 66. Tenofovir Alafenamide Fumarate Tablets Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Tenofovir Alafenamide Fumarate Tablets Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Tenofovir Alafenamide Fumarate Tablets Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Tenofovir Alafenamide Fumarate Tablets Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Tenofovir Alafenamide Fumarate Tablets Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Tenofovir Alafenamide Fumarate Tablets Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Tenofovir Alafenamide Fumarate Tablets Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Tenofovir Alafenamide Fumarate Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Tenofovir Alafenamide Fumarate Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Tenofovir Alafenamide Fumarate Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Tenofovir Alafenamide Fumarate Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Tenofovir Alafenamide Fumarate Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Tenofovir Alafenamide Fumarate Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Tenofovir Alafenamide Fumarate Tablets Raw Material
Table 126. Key Manufacturers of Tenofovir Alafenamide Fumarate Tablets Raw Materials
Table 127. Tenofovir Alafenamide Fumarate Tablets Typical Distributors
Table 128. Tenofovir Alafenamide Fumarate Tablets Typical Customers
List of Figures
Figure 1. Tenofovir Alafenamide Fumarate Tablets Picture
Figure 2. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Type in 2022
Figure 4. Original Drugs Examples
Figure 5. Generic Drugs Examples
Figure 6. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Other Examples
Figure 11. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Tenofovir Alafenamide Fumarate Tablets Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Tenofovir Alafenamide Fumarate Tablets by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Tenofovir Alafenamide Fumarate Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Tenofovir Alafenamide Fumarate Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Tenofovir Alafenamide Fumarate Tablets Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Tenofovir Alafenamide Fumarate Tablets Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Region (2018-2029)
Figure 53. China Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Tenofovir Alafenamide Fumarate Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Tenofovir Alafenamide Fumarate Tablets Market Drivers
Figure 74. Tenofovir Alafenamide Fumarate Tablets Market Restraints
Figure 75. Tenofovir Alafenamide Fumarate Tablets Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Tenofovir Alafenamide Fumarate Tablets in 2022
Figure 78. Manufacturing Process Analysis of Tenofovir Alafenamide Fumarate Tablets
Figure 79. Tenofovir Alafenamide Fumarate Tablets Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
